For the Inventor, By the Inventor

Enter assignee name

Jacobio Pharmaceuticals Co., Ltd.

USPTO Granted Patents = 15

CIPO Patents = 1

EPO Patents = 2

Forward Citations = 20

Loading Chart...

Loading Chart...

37 inventors (with patents filed for the assignee):

Amin Li (6 out of 6 patents)

Peng Wang (5 out of 96 patents)

Sujing Li (5 out of 5 patents)

4. Dan Liu (5 out of 42 patents)

5. Chaojie Dang (5 out of 5 patents)

6. Guiqun Yang (4 out of 4 patents)

7. Mingming Chen (3 out of 5 patents)

8. Qinghao Liu (3 out of 3 patents)

9. Haiyan Yang (3 out of 5 patents)

10. Wenlai Zhou (3 out of 3 patents)

11. Hongling Wang (3 out of 3 patents)

12. Cunbo Ma (3 out of 8 patents)

13. Shaojing Hu (3 out of 14 patents)

14. Panliang Gao (3 out of 3 patents)

15. Di Kang (3 out of 3 patents)

15 patents: Sort by Forward Citations

1. 12391756 - Binding molecule specific for CD39 and use thereof (2025-08-19),

2. 12281168 - Binding molecule specific for LIF and use thereof (2025-04-21),

3. 12233062 - Heterocyclic derivatives useful as SHP2 inhibitors (2025-02-25),

4. 12195473 - KRAS mutant protein inhibitors (2025-01-14),

5. 12103929 - Tricyclic compounds (2024-10-01),

6. 11787811 - KRAS mutant protein inhibitors (2023-10-17),

7. 11466005 - Tricyclic compounds (2022-10-11),

8. 11384066 - Heterocyclic compounds useful as aurora a selective inhibitors (2022-07-12),

9. 11345701 - KRAS mutant protein inhibitors (2022-05-31),

10. 11180506 - KRAS mutant protein inhibitors (2021-11-23),

11. 11174319 - Binding molecule specific for CD73 and use of binding molecule (2021-11-16),

12. 11161847 - KRAS mutant protein inhibitors (2021-11-02),

13. 11136320 - Fused ring derivative used as FGFR4 inhibitor (2021-10-05),

14. 10988466 - Heterocyclic derivatives useful as SHP2 inhibitors (2021-04-27),

15. 10858359 - Heterocyclic ring derivatives useful as SHP2 inhibitors (2020-12-08),

Jacobio Pharmaceuticals Co., Ltd. is a leading biopharmaceutical company focused on the discovery and development of innovative therapies for cancer and autoimmune diseases. With a strong emphasis on research and development, Jacobio is committed to bringing life-changing treatments to patients around the world. Through strategic partnerships and collaborations, Jacobio aims to accelerate the delivery of new medicines to address unmet medical needs.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

15 Patents

#174 in Beijing

#1,708 in China

#38,719 in the World

Jacobio Pharmaceuticals Co., Ltd.

Forward Citations = 20

37 inventors:

Amin Li (6 out of 6 patents)

Peng Wang (5 out of 96 patents)

Sujing Li (5 out of 5 patents)

4. Dan Liu (5 out of 42 patents)

5. Chaojie Dang (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…